Delivering results that impact companies and change patient care.
The Interdependence team has deep experience in working with biotechnology companies across stakeholders and throughout the scientific Phases of drug development with a proven track record for building anticipation, defining need, engaging in scientific storytelling and optimizing launches. Team members have experience working with large, established companies, as well as start-ups and early-stage brands. Client experience includes Celgene, Exelixis, Amgen, CytomX, Tyme Technologies, IMV and more.
No matter size or stage of science development, a clear narrative delivered with urgency and clarity to the targeted stakeholders matters. Interdependence knows how to create messages that resonate and reach the right media when it counts. We match your precision for science with strategically informed and expertly executed public relations that deliver the media and influencers that move your business goals forward.
Ultimately, combining traffic-informed, news-cycle driven opportunities with customized creative pitches is an approach that helps increase pitch conversion by 300 to 400 percent for our clients. More important, because we’re timely and targeted, our media placements bring an influx of traffic to your website, convert users, acquire partners, drive thought leadership, gain competitive foothold, secure investor interest and increase your valuation.
Marrying your science with what’s important to media and your stakeholders is what we do. Our approach delivers timely results that matter to you and, ultimately, helps you deliver on your promise to patients.